Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innovative Bioanalysis is a private, California-based full-service reference and bioanalytical laboratory serving clinical research, diagnostics, and device-efficacy testing needs. The company provides central lab and bioanalytical services including LC/MS, immunoassays, RT-PCR, flow cytometry, HPLC, ELISA/EIA, hematology, coagulation, urinalysis, and microbiology support. It also markets BSL-2/BSL-3 testing capabilities for pathogen and air/surface device efficacy studies, including work related to viral and microbial inactivation. Rather than operating a therapeutic drug pipeline, the company appears to function primarily as a contract research and testing services provider for sponsors, device companies, and clinical investigators. Public materials indicate CAP and CLIA accreditation and emphasize expedited turnaround, sample storage, data management, statistical analysis, and PK assay validation services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innovative Bioanalysis.